EU drug watchdog deals another blow to Cladribine

Mavenclad is an oral treatment for relapsing MS and active secondary progressive MS.
Post Reply
User avatar
MSUK
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm
Contact:

EU drug watchdog deals another blow to Cladribine

Post by MSUK » Fri Jan 21, 2011 12:52 am

Image

European regulators dealt Merck KGaA another blow by sticking with their recommendation against what once was the group's biggest pipeline hope, multiple sclerosis (MS) pill cladribine.

The European Union's drugs watchdog, which had already recommended against cladribine in September, prompting an appeal from Merck, still found that the benefits of cladribine tablets did not outweigh its risks, Merck said on Friday.

The regulator, whose view is invariably adopted by the European Commission for approval decisions, had in September mainly taken issue with cases of cancer........Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1629
MS-UK - http://www.ms-uk.org/

Post Reply
  • Similar Topics
    Replies
    Views
    Last post